224 related articles for article (PubMed ID: 18041430)
1. Survival time of HIV-infected patients with cryptococcal meningitis.
Chottanapund S; Singhasivanon P; Kaewkungwal J; Chamroonswasdi K; Manosuthi W
J Med Assoc Thai; 2007 Oct; 90(10):2104-11. PubMed ID: 18041430
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of AIDS-associated cryptomeningitis.
Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S
BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.
Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Chottanapund S; Mankatitham W; Chimsuntorn S; Sittibusaya C; Moolasart V; Chaovavanich A
J Med Assoc Thai; 2008 Feb; 91(2):159-65. PubMed ID: 18389979
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.
Chetchotisakd P; Sungkanuparph S; Thinkhamrop B; Mootsikapun P; Boonyaprawit P
HIV Med; 2004 May; 5(3):140-3. PubMed ID: 15139978
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.
Manosuthi W; Chaovavanich A; Tansuphaswadikul S; Prasithsirikul W; Inthong Y; Chottanapund S; Sittibusaya C; Moolasart V; Termvises P; Sungkanuparph S
J Infect; 2007 Nov; 55(5):464-9. PubMed ID: 17714788
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.
Lee YC; Wang JT; Sun HY; Chen YC
J Microbiol Immunol Infect; 2011 Oct; 44(5):338-45. PubMed ID: 21524972
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
[TBL] [Abstract][Full Text] [Related]
11. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
Skiest DJ; Hester LJ; Hardy RD
J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-RodrÃguez M
Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcal meningitis in HIV infected: experience from a North Indian tertiary center.
Kumar S; Wanchu A; Chakrabarti A; Sharma A; Bambery P; Singh S
Neurol India; 2008; 56(4):444-9. PubMed ID: 19127040
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
15. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
[TBL] [Abstract][Full Text] [Related]
16. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.
Park BJ; Shetty S; Ahlquist A; Greenbaum A; Miller JL; Motsi A; McCarthy K; Govender N;
Int J STD AIDS; 2011 Apr; 22(4):199-203. PubMed ID: 21515751
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL.
Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Inthong Y; Prasithsirikul W; Chottanapund S; Mankatitham W; Chimsuntorn S; Sittibusaya C; Moolasart V; Chumpathat N; Termvises P; Chaovavanich A
Int J STD AIDS; 2007 Nov; 18(11):782-6. PubMed ID: 18005514
[TBL] [Abstract][Full Text] [Related]
19. Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.
Tansuphaswadikul S; Maek-a-Nantawat W; Phonrat B; Boonpokbn L; Mctm AG; Pitisuttithum P
J Med Assoc Thai; 2006 Oct; 89(10):1677-85. PubMed ID: 17128844
[TBL] [Abstract][Full Text] [Related]
20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
